rss
J Neurol Neurosurg Psychiatry 2006;77:1103 doi:10.1136/jnnp.2006.095505
  • Underestimated risk for stroke patients
  • Editorial commentary

MTHFR 677 TT genotype and hyperhomocysteinaemia: an underestimated risk TANDEM for patients with stroke

  1. V Caso,
  2. M Paciaroni
  1. Stroke Unit, Ospedale Silvestrini, Perugia, Italy
  1. Correspondence to:
 V Caso
 Stroke Unit, Ospedale Silvestrini, San’ Andrea delle Fratte, 06146 Perugia, Italy;vcaso{at}hotmail.com
  • Published Online First 16 June 2006

Synergy between hyperhomocysteinaemia and conventional risk factors for stroke

Hyperhomocysteinaemia (hyperH(e)) is still considered to be one of the less documented risk factors for stroke.1 One of the most frequent causes of hyperH(e) is a single-nucleotide polymorphism in the gene methylenetetrahydrofolate reductase (MTHFR). The homozygotic TT genotype is found in approximately 10–12% of the population and is associated with a 25% higher homocysteine level in patients with than in those without this mutation.1

The distribution of the MTHFR 677 TT genotype and hyperH(e) in young patients with stroke aged <45 years was compared with that in healthy controls in the paper by Pezzini et al2 (see p …

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest neurology and neurosurgery jobs